Open house Doravirin discount agreements

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Apr 03, 2028 · 584 days left·Open·Supplies·Framework

Structured notice only

Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Doravirin, ATC J05AG06

50/100

Opportunity Score

Needs reviewLow complexity

SuppliesFrameworkOpen

Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

No estimated value or framework maximum value is provided. The commercial opportunity cannot be quantified.

Open-house agreements automatically expire if a traditional procurement discount contract (federal or state level) is s...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Overview

Moderate opportunity

Key Facts

Framework procurement
Supplies contract
1 lot
Duration until May 2028
Supply of Doravirin (ATC J05AG06) pharmaceutical products
Non-exclusive discount agreements with AOK Bayern

Show full summary

Open-house model (non-exclusive) for discount agreements on the active substance Doravirin (ATC J05AG06) with AOK Bayern. All eligible pharmaceutical companies can join identical, non-negotiable contracts for the period 01.06.2026 to 31.05.2028. No estimated value provided. No formal award criteria since no selection takes place. Submission via signed declaration of reliability; physical or electronic with qualified signature accepted. Contracts can be concluded at any time until 03.04.2028.

Risks

No estimated value or framework maximum value is provided. The commercial opportunity cannot be quantified.

Open-house agreements automatically expire if a traditional procurement discount contract (federal or state level) is s...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Certifications

Eligibility: signed declaration of reliability (self-certification form)
Language: documents must be in German or accompanied by a certified German translation

Administrative

Submission: physical (2 copies original, hand-signed) or electronic (qualified electronic signature) via DTVP portal

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria – open-house model, no selection among participants.

Buyer

Name

AOK Bayern - Die Gesundheitskasse

Location

München, DEU

[email protected]

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house Doravirin discount agreements

Non-exclusive discount agreements for Doravirin (ATC J05AG06) with AOK Bayern. Contracts run from 01.06.2026 to 31.05.2028. Open to all pharmaceutical companies meeting eligibility. No selection – all who apply and meet criteria get a contract. Submission deadline: contracts can be signed until 03.04.2028 (monthly cut-off dates apply for start dates).

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

May 2026 - May 2028

Procurement Details

Publication date: 14 Apr 2026
Languages: German

Reference metadata

Legal basis: 32014L0024

Reference IDs

Tender ID: 257844-2026

Documents (2)

Procurement document 1 Submission portal 1

Similar tenders

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3